These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 20186684)
1. Late stroke after foam sclerotherapy. Hahn M; Schulz T; Jünger M Vasa; 2010 Feb; 39(1):108-10. PubMed ID: 20186684 [TBL] [Abstract][Full Text] [Related]
2. Stroke after varicose vein foam injection sclerotherapy. Forlee MV; Grouden M; Moore DJ; Shanik G J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404 [TBL] [Abstract][Full Text] [Related]
3. Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale. Matsuzono K; Arai N; Suzuki M; Kim Y; Ozawa T; Mashiko T; Shimazaki H; Koide R; Matsuura T; Fujimoto S J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e110-e112. PubMed ID: 29402614 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Rabe E; Otto J; Schliephake D; Pannier F Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905 [TBL] [Abstract][Full Text] [Related]
5. Reversible neurological deficit after foam sclerotherapy. Hartmann K; Harms L; Simon M Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):648-9. PubMed ID: 19683463 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of right-to-left shunt in patients with symptomatic great saphenous incompetence and varicose veins. Wright DD; Gibson KD; Barclay J; Razumovsky A; Rush J; McCollum CN J Vasc Surg; 2010 Jan; 51(1):104-7. PubMed ID: 19837542 [TBL] [Abstract][Full Text] [Related]
7. Venous disorders: treatment with sclerosant foam. Bergan J; Pascarella L; Mekenas L J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941 [TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy: a study comparing polidocanol in foam and liquid form. Uncu H Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346 [TBL] [Abstract][Full Text] [Related]
9. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712 [TBL] [Abstract][Full Text] [Related]
10. Acute Ischemic Stroke in a Young Woman With No Known Risk Factors. Abdelhamid N; Farooq S; Sarraj A WMJ; 2018 Mar; 117(1):42-44. PubMed ID: 29677415 [TBL] [Abstract][Full Text] [Related]
11. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam. Reich-Schupke S; Weyer K; Altmeyer P; Stücker M Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673 [TBL] [Abstract][Full Text] [Related]
12. Sclerotherapy and foam sclerotherapy for varicose veins. Coleridge Smith P Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382 [TBL] [Abstract][Full Text] [Related]
13. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures. King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872 [TBL] [Abstract][Full Text] [Related]
14. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results. Gonzalez-Zeh R; Armisen R; Barahona S J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418 [TBL] [Abstract][Full Text] [Related]
15. Three cases of stroke following peripheral venous interventions. Ma RW; Pilotelle A; Paraskevas P; Parsi K Phlebology; 2011 Oct; 26(7):280-4. PubMed ID: 21422195 [TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial. Ukritmanoroat T J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876 [TBL] [Abstract][Full Text] [Related]